Partnering and Licensing

Myriad is actively seeking strategic collaborations, in-licensing opportunities, and acquisitions to further expand our pipeline of transformative molecular diagnostic tests.  We have a strong commitment to being a leader in the molecular diagnostic field, and we understand the value of building strong partnerships with other companies and laboratories to accomplish this strategic goal. We focus on six, specialty medical fields: Oncology, Preventive Care, Urology, Dermatology, Autoimmune disorders and Neuroscience diseases.  We have a proven track record of building strong, collaborative relationships with world-renowned research and clinical centers; through these important partnerships we have been able to Enhance, individualize and improve patient care. We welcome the chance to review details of a prospective opportunity within our medical area of interest. Please send us non-confidential information concerning your technology, content, or molecular diagnostic test as well as an overview on your institution.

For opportunities that involve Myriad tests or pipeline products for use as companion diagnostics, please contact:

Patrick M. Burke, PhD
VP, Strategic Collaborations
Myriad Genetics, Inc.
Tel. +1 801 584-1195

For early stage technology opportunities, please contact:

John Gill, JD, MBA
Senior Director, Business Development
Myriad Genetics, Inc.
Tel +1 801 746-6513